Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Stern

Showing results (11-20 of 139) with videos related to

Pageof 14
Sort By:
The Practitioner|October 1, 1977
Choice of treatment in Parkinson's diseaseG M Stern, A J Lees
Lancet (London, England)|September 12, 1981
Pergolide and lisuride for levodopa-induced oscillationsA J Lees, G M Stern
Lancet (London, England)|May 25, 1974
Letter: Lithium and haloperidol in movement disordersJ A McCaul, G M Stern
American Heart Journal|October 1, 1971
Parkinsonism and the hypotension caused by L-dopaG M Stern, K R Hunter
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1991
Subcutaneous and sublingual levodopa methyl ester in Parkinson's diseaseB Kleedorfer, A J Lees, G M Stern
Lancet (London, England)|February 3, 1973
Melatonin and parkinsonismK M Shaw, G M Stern, M Sandler
Brain Research. Developmental Brain Research|May 20, 1997
Influence of BDNF on the expression of the dopaminergic phenotype of tissue used for brain transplantsJ Zhou, H F Bradford, G M Stern
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1987
Mesulergine and pergolide in previously untreated Parkinson's diseaseA Wright, A J Lees, G M Stern
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1986
Respiration and sleep in Parkinson's diseaseR J Hardie, J Efthimiou, G M Stern
Brain Research. Developmental Brain Research|September 16, 1994
The stimulatory effect of brain-derived neurotrophic factor on dopaminergic phenotype expression of embryonic rat cortical neurons in vitroJ Zhou, H F Bradford, G M Stern
Pageof 14

Showing results (11-20 of 139) with videos related to

Sort By:
Pageof 14
The Practitioner|October 1, 1977
Choice of treatment in Parkinson's diseaseG M Stern, A J Lees
Lancet (London, England)|September 12, 1981
Pergolide and lisuride for levodopa-induced oscillationsA J Lees, G M Stern
Lancet (London, England)|May 25, 1974
Letter: Lithium and haloperidol in movement disordersJ A McCaul, G M Stern
American Heart Journal|October 1, 1971
Parkinsonism and the hypotension caused by L-dopaG M Stern, K R Hunter
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1991
Subcutaneous and sublingual levodopa methyl ester in Parkinson's diseaseB Kleedorfer, A J Lees, G M Stern
Lancet (London, England)|February 3, 1973
Melatonin and parkinsonismK M Shaw, G M Stern, M Sandler
Brain Research. Developmental Brain Research|May 20, 1997
Influence of BDNF on the expression of the dopaminergic phenotype of tissue used for brain transplantsJ Zhou, H F Bradford, G M Stern
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1987
Mesulergine and pergolide in previously untreated Parkinson's diseaseA Wright, A J Lees, G M Stern
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1986
Respiration and sleep in Parkinson's diseaseR J Hardie, J Efthimiou, G M Stern
Brain Research. Developmental Brain Research|September 16, 1994
The stimulatory effect of brain-derived neurotrophic factor on dopaminergic phenotype expression of embryonic rat cortical neurons in vitroJ Zhou, H F Bradford, G M Stern
Pageof 14